Skip to content

Validation and standardization of the measurement of pelvic floor dysfunction with the MAPLE-probe

Validation and standardization of the measurement of pelvic floor dysfunction with the MAPLE-probe - Validation of the MAPLE-probe

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON39307
Enrollment
50
Registered
2008-08-22
Start date
2009-11-09
Completion date
Unknown
Last updated
2024-06-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

pelvic floor urge urinary incontinence

Interventions

None listed

Sponsors

Leids Universitair Medisch Centrum
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Patients with pelvic floor dysfunction

Exclusion criteria

Exclusion criteria: women with neurological diseases

Design outcomes

Primary

MeasureTime frame
To detect significant differences in measurement with the common used probes and the MAPLe. To validate the MAPLe. To improve complaints of Urgency/Frequency and/or Urge Urinary Incontinence

Secondary

MeasureTime frame
Quality of Life

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)